Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase II Trial Evaluating Irinotecan and Capecitabine Relapsed/Refractory Upper GI Tumours
This study is ongoing, but not recruiting participants.
Study NCT00220168.   Last updated on October 10, 2006.
Information provided by Royal Marsden NHS Foundation Trust
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Upper Gastrointestinal Tumours
Additional conditions recognized in this trial
Digestive System Neoplasms
Gastrointestinal Neoplasms
More general conditions related to this trial
Digestive System Diseases
Gastrointestinal Diseases
Neoplasms
Neoplasms by Site
Interventions listed in this trial
Irinotecan, Capecitabine
Additional drug interventions recognized in this trial
Capecitabine
Irinotecan
More general drug interventions related to this trial
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antineoplastic Agents, Phytogenic
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Royal Marsden NHS Foundation Trust


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services